A miRNA-Based Gene Therapy Approach to Target Mutated SOD1 in Key Cell Types in Amyotrophic Lateral Sclerosis {ALS}


Published in:
Mol. Ther.
Year:
2018
Laboratories:




 Record created 2018-11-08, last modified 2018-11-08


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)